SQUAWK/NEWS
Menu
Live News EQUITY L impact

AZN Astrazeneca: breztri is now available in US as first and only fixed-dose triple therapy for asthma patients 12 years of age and older

AZN Astrazeneca: breztri is now available in US as first and only fixed-dose triple therapy for asthma patients 12 years of age and older

AZN
SquawkNews Newsroom 1 updates Updated Jul 20, 2026, 01:39 PM UTC

Story updates

01:39:13 PM UTC
SquawkNews
AstraZeneca’s Breztri Available In US As First And Only Fixed-Dose Triple Therapy For Asthma Patients +12 Years

AZN Astrazeneca: breztri is now available in US as first and only fixed-dose triple therapy for asthma patients 12 years of age and older